Skip to main content
Caplight Logo









Diligent Pharma

Diligent Pharma

Private
Princeton, New JerseyHealthcare & Life Scienceshttps://www.diligentpharma.com/

Last Round

Series A

May 15, 2023

Total Funding Raised

$8.27M

Company Overview

Diligent Pharma is a pharmaceuticals and biotechnology company that provides a cloud-based research platform designed to streamline the selection and qualification of clinical trial service providers.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Compliance & Risk, Vertical SaaS, Quality Management

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical trial managementvendor qualificationclinical research organizationCROGxP compliancevendor risk managementlife sciences softwarevertical SaaSclinical trial startupeQMSelectronic quality management systemregulatory complianceRFI managementpharma techclinical operationscompliance automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Diligent Pharma Comparables

Compare Diligent Pharma with similar companies based on industry and business-model similarity.

Diligent Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Strategikon Pharma
76%
ClinAI
74%
Veeva Systems
72%

Diligent Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 15, 2023

Key People

Founding team and executive leadership

Patricia Leuchten

Founder and CEO, Founder and Owner

Founding Team

Christopher Sallemi

Chief Technology Officer, Head Of The Diligent Innovation Lab

Executive Team

Diligent Pharma Investors

Notable investors and investment history

Diligent Pharma investors
InvestorRounds
GenHenn CapitalSeries A
PJCSeries A
FCA Venture PartnersSeries A

Diligent Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Diligent Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Diligent Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersPrinceton, New Jersey
Employee Range25
Year Founded2015
Last FundingMay 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.